galdor.xyz
Admin
Compass Pathways Drug Approval·closes in 5mo

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027?

YES means Before Mar 1, 2027

24h volume
0
2,885 lifetime
Open interest
2,316
Spread
4¢
5 × 23 at the touch
24h range
–
Chance of YES
71%

A YES contract costs 75¢ and pays $1 if it happens.

NO
29%

costs 29¢

YES bid / ask
71¢ / 75¢
NO bid / ask
25¢ / 29¢
What Galdor thinks

An independent read of this market

1Reads the rules literallySettlement source, close time, and the edge cases that flip an outcome.
2Checks the tape and the webOrder book, flow, price history, then targeted searches with sources.
3Gives a straight answerA probability with a band, and one of four calls: YES, NO, wait, or stay out.

Generated by an AI analyst from live exchange data and public web sources. Research and analytics, not investment advice. Markets can move after this was written.

Price history

YES price per candle with the bid/ask band, volume underneath. Times in UTC.

24h7d30d90d
Not enough history to chart.

Order book

Resting orders, both sides shown as YES prices. Bars are size.

Yes ask (no bid)SizeYes
  • ask5099¢
  • ask2,22297¢
  • ask5096¢
  • ask1,28895¢
  • ask15794¢
  • ask46290¢
  • ask9.8580¢
  • ask2375¢
spread4¢mid 73¢
  • bid571¢
  • bid1570¢
  • bid25069¢
  • bid1558¢
  • bid50055¢
  • bid2.1845¢
  • bid5138¢
  • bid99837¢
Yes bid (no ask)SizeYes

How this market resolves

Verbatim from Kalshi. Read this before the price.

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Mar 1, 2027, then the market resolves to Yes.

Settlement sources
opened
May 16 · 2:35 AM UTC
closes
Mar 1, 2027 · 4:59 AM UTC · may close early
settles by
Jan 1, 2028 · 3:00 PM UTC
ticker
KXFDAAPPROVALDATECMPS-360-27MAR01
Trade it on kalshi.com

Other outcomes in this event

Outcomes in this event settle independently.

Prices are YES cost in cents and approximate the market’s implied probability. Data is read live from the Kalshi Trade API on every page load. galdor.xyz places no orders and holds no positions. Research and analytics, not investment advice.